Synopsys: A Derisked Growth Story With Ansys Driving The Next Leg

Synopsys (SNPS) is rated a Buy with a $519.12 12-month price target, reflecting derisked China headwinds and Ansys-driven growth. China-related revenue disruptions are fully factored into guidance, offering pure upside if conditions improve, while downside is limited. The Ansys acquisition expands SNPS's TAM by 1.5x and accelerates integration of multiphysics simulation, enhancing cross-selling and competitive positioning.
Open original source